Home › Multiple Sclerosis › Florida › Gainesville
Multiple Sclerosis clinical trials in Gainesville, FL
4 studies for Multiple Sclerosis are looking for participants at sites in and around Gainesville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
Recruiting
- Norman Fixel Institute for Neurological Diseases, Gainesville
- University of Florida, Gainesville
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
RecruitingObservational study
- TG Therapeutics Investigational Trial Site, Gainesville
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
RecruitingPhase 3
- Norman Fixel Institute for Neurological Diseases (FIND)- Site Number : 8400054, Gainesville
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
RecruitingPhase 3
- UF Health Cancer Center, Gainesville
About Multiple Sclerosis
Multiple sclerosis (MS) slows down or blocks messages between the brain and body. MS can be mild or severe. Learn about MS symptoms and treatment.
More about Multiple Sclerosis on MedlinePlus
Multiple Sclerosis trials in other cities
- New York City, NY17 studies
- Chicago, IL15 studies
- Boston, MA14 studies
- Washington, DC13 studies
- Cleveland, OH10 studies
- Birmingham, AL9 studies
- Aurora, CO8 studies
- Kansas City, KS8 studies
- St. Louis, MO8 studies
- San Francisco, CA8 studies
- Tampa, FL7 studies
- Dallas, TX7 studies
Other studies in Gainesville
- Heart Failure13 studies
- Type 1 Diabetes13 studies
- Parkinson's Disease12 studies
- Non-Small Cell Lung Cancer11 studies
- Breast Cancer11 studies
- Cancer (all types)9 studies
- Colorectal Cancer9 studies
- Cardiovascular Disease9 studies
- Lung Cancer9 studies
- Prostate Cancer8 studies
- Mild Cognitive Impairment8 studies
- Neuroblastoma7 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.